In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.

On the basis of preliminary in vitro data, we evaluated E-1040, a new cephalosporin, against 188 cystic fibrosis (CF) sputum isolates obtained from 26 CF centers in the United States. These isolates included mucoid and nonmucoid Pseudomonas aeruginosa, Pseudomonas cepacia, Staphylococcus aureus, Hae...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Stutman, H R, Akaniro, J C, Vidaurre, C E, Marks, M I
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175982/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2386368/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.7.1366
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!